The latest research study “Nutrigenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global nutrigenomics market size reached US$ 944.82 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 2,042.4 Million by 2027, exhibiting a growth rate (CAGR) of 12.50% during 2022-2027.
Nutrigenomics, also called nutritional genomics, represents a subset of medical science that analyzes the relationship between nutrition and the human genome. It usually focuses on understanding the correlation between genes and diet and their effect on human health and the risk of developing diseases, such as cardiovascular diseases (CVDs), obesity, cancer, etc.
Nutrigenomics helps in detecting factors of aging as well as disease predisposition and creating personalized diet or nutrition plans depending on genotype. It also aids in understanding the toxicity and safety profile of macro- and micronutrients and preventing diet-associated diseases. Furthermore, nutrigenomics testing is generally done by taking samples of buccal swabs, blood, saliva, etc.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a free sample brochure:
Nutrigenomics Market Trends and Drivers:
The growing prevalence of obesity is primarily driving the nutrigenomics market. Additionally, the rising consumer inclination towards health and fitness and the escalating demand for personalized nutrition products, especially among fitness enthusiasts and athletes, are further catalyzing the market growth. Besides this, the increasing investments in R&D activities to introduce potential cures and innovative medicine using human genetics as a basis for discovery are acting as significant growth-inducing factors.
Moreover, they are focusing on developing tailor-made food to match a particular gene profile, such as decreasing the intake of cholesterol compounds and strengthening the weak immune system, which is acting as another significant growth-inducing factor. Apart from this, the elevating incidences of nutritional deficiency disorders, including lack of folate, iron anemia, vitamins D and K, hypocalcemia, osteomalacia, xerophthalmia, scurvy, pellagra, rickets, etc., are anticipated to fuel the nutrigenomics market over the forecasted period.
Nutrigenomics Market Report Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- BASF SE
- Cura Integrative Medicine
- Danone S.A
- Genova Diagnostics
- Holistic Health International
- Koninklijke DSM N.V.
- Metagenics Inc.
- Nutrigenomix Inc. and Xcode Life.
The report has been segmented the market into following categories:
- Reagents and Kits
- Buccal Swab
- Cardiovascular Diseases
- Cancer Research
- Sport Clinics
- Corporate Programs
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.